Erlotinib appears to be effective against adenocarcinomas of the gastro-oesophageal junction (distal oesophagus and gastric cardia; GEJ), but not gastric adenocarcinomas

Author:  

Publisher: Adis International

ISSN: 1173-8324

Source: Inpharma, Vol.1, Iss.1562, 2006-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract